106 results
DEFA14A
VIR
Vir Biotechnology Inc
14 May 24
Additional proxy soliciting materials
4:05pm
any indication, assurance or guarantee that the assumptions on which such forward-looking statements have been made are correct or exhaustive … extent sotrovimab may be reauthorized for use by the FDA in any U.S. region in the future. In addition, there can be no assurance with respect to how
S-3ASR
mr0v1o zon2j9
3 Nov 23
Automatic shelf registration
4:33pm
S-3ASR
EX-1.2
l2bep1ock17ze8icis9l
3 Nov 23
Automatic shelf registration
4:33pm
8-K
3j5ey7d4hptu
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am